Penumbra Inc (PEN) financials
Penumbra Inc (PEN) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.
In fiscal 2025, Penumbra Inc reported revenue of $1.40B, up 17.5% year over year, net income of $178M, diluted EPS of $4.52 and free cash flow of $175M.
- Revenue (fiscal 2025)
- $1.40B
- Revenue growth (fiscal 2025)
- 17.5%
- Net income (fiscal 2025)
- $178M
- Diluted EPS (fiscal 2025)
- $4.52
- Free cash flow (fiscal 2025)
- $175M
Penumbra Inc files with the U.S. Securities and Exchange Commission under CIK 0001321732, classified as Surgical & Medical Instruments & Apparatus.
Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.